Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.62347/TORU2999
Baoping Zhao, Siwei Luo, Jialin He, Long Yang, Qiang Zou, Meng Zhang, Benyan Wang, Huihui Yu, Hao Guo, Chuan Ye
Objective: This study aimed to compare the clinical efficacy of mechanically activated tissue retractor (MATR) combined with vacuum sealing drainage (VSD) versus conventional VSD for treating deep soft tissue defects.
Methods: This prospective study included 53 patients with deep soft tissue defects treated between July 2024 and April 2025. The combination group (26 patients) received MATR combined with VSD, while the control group (27 patients) received conventional VSD. Outcome measures included defect healing time, rate of defect healing, mature granulation, graft survival status, pain (Visual Analog Scale, VAS), functional mobility (Activities of Daily Living Scale, ADLS), scarring (Vancouver Scar Scale, VSS), and perioperative complications. Chi-square test, t-test, and ANOVA were used to compare differences.
Results: The combination group demonstrated a significantly shorter defect healing time and lower perioperative complication rate than the control group (all P < 0.05). At 14 days and 21 days after surgery, the combination group demonstrated superior defect healing, mature granulation, and skin survival status compared to the control group (all P < 0.05). Additionally, the combination group had significantly lower VAS scores and higher ADLS scores than the control group (all P < 0.05). At 3 months after defect healing, the combination group again showed significantly lower VAS and VSS scores, and higher ADLS scores than the control group (all P < 0.05).
Conclusion: MATR combined with VSD was more effective in treating deep soft tissue defects compared to conventional VSD.
{"title":"Clinical efficacy of mechanically activated tissue retractor combined with vacuum sealing drainage for treating deep soft tissue defects: a prospective study.","authors":"Baoping Zhao, Siwei Luo, Jialin He, Long Yang, Qiang Zou, Meng Zhang, Benyan Wang, Huihui Yu, Hao Guo, Chuan Ye","doi":"10.62347/TORU2999","DOIUrl":"10.62347/TORU2999","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to compare the clinical efficacy of mechanically activated tissue retractor (MATR) combined with vacuum sealing drainage (VSD) versus conventional VSD for treating deep soft tissue defects.</p><p><strong>Methods: </strong>This prospective study included 53 patients with deep soft tissue defects treated between July 2024 and April 2025. The combination group (26 patients) received MATR combined with VSD, while the control group (27 patients) received conventional VSD. Outcome measures included defect healing time, rate of defect healing, mature granulation, graft survival status, pain (Visual Analog Scale, VAS), functional mobility (Activities of Daily Living Scale, ADLS), scarring (Vancouver Scar Scale, VSS), and perioperative complications. Chi-square test, t-test, and ANOVA were used to compare differences.</p><p><strong>Results: </strong>The combination group demonstrated a significantly shorter defect healing time and lower perioperative complication rate than the control group (all <i>P</i> < 0.05). At 14 days and 21 days after surgery, the combination group demonstrated superior defect healing, mature granulation, and skin survival status compared to the control group (all <i>P</i> < 0.05). Additionally, the combination group had significantly lower VAS scores and higher ADLS scores than the control group (all <i>P</i> < 0.05). At 3 months after defect healing, the combination group again showed significantly lower VAS and VSS scores, and higher ADLS scores than the control group (all <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>MATR combined with VSD was more effective in treating deep soft tissue defects compared to conventional VSD.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9894-9904"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.62347/AHPX9239
Xuehui Zhang, Dongdong Zhou, Jinguo Chu
Objectives: To investigate the expression of serum Interleukin-17 (IL-17) and its receptor IL-17R in patients with bacterial pneumonia and their diagnostic value for severe bacterial pneumonia.
Methods: In this retrospective analysis, 172 patients diagnosed with bacterial pneumonia were included and categorized into the severe (n = 61) and non-severe (n = 111) groups. Serum concentrations of IL-17, IL-17R, procalcitonin (PCT), and high-sensitivity C-reactive protein (hs-CRP) were measured using ELISA upon admission and after antibiotic treatment. ROC curves were drawn to assess the diagnostic performance of influencing factors, correlation analyses were performed to explore relationships among biomarkers, and logistic regression to identify independent risk factors.
Results: Before treatment, patients with severe bacterial pneumonia demonstrated significantly higher levels of IL-17, IL-17R, PCT, and hs-CRP compared to non-severe patients (all P < 0.001). All biomarkers decreased significantly after treatment in severe group (all P < 0.05). IL-17 and IL-17R showed good accuracy in identifying severe disease (AUC = 0.808 and 0.777, respectively) and were positively correlated with PCT and hs-CRP (all P < 0.05). Multivariate analysis identified IL-17, IL-17R, PCT, and hs-CRP as independent risk factors for severe bacterial pneumonia.
Conclusions: IL-17 and IL-17R are elevated in bacterial pneumonia, demonstrating close association with disease severity and conventional markers. Their decline after treatment indicates therapeutic effectiveness. These cytokines show diagnostic potential and could help monitor disease progression and treatment response. Future research should confirm these findings in larger cohorts and investigate their interactions with other inflammatory pathways.
{"title":"Expression and clinical significance of IL-17 and its receptor in bacterial pneumonia before and after treatment.","authors":"Xuehui Zhang, Dongdong Zhou, Jinguo Chu","doi":"10.62347/AHPX9239","DOIUrl":"10.62347/AHPX9239","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the expression of serum Interleukin-17 (IL-17) and its receptor IL-17R in patients with bacterial pneumonia and their diagnostic value for severe bacterial pneumonia.</p><p><strong>Methods: </strong>In this retrospective analysis, 172 patients diagnosed with bacterial pneumonia were included and categorized into the severe (n = 61) and non-severe (n = 111) groups. Serum concentrations of IL-17, IL-17R, procalcitonin (PCT), and high-sensitivity C-reactive protein (hs-CRP) were measured using ELISA upon admission and after antibiotic treatment. ROC curves were drawn to assess the diagnostic performance of influencing factors, correlation analyses were performed to explore relationships among biomarkers, and logistic regression to identify independent risk factors.</p><p><strong>Results: </strong>Before treatment, patients with severe bacterial pneumonia demonstrated significantly higher levels of IL-17, IL-17R, PCT, and hs-CRP compared to non-severe patients (all P < 0.001). All biomarkers decreased significantly after treatment in severe group (all P < 0.05). IL-17 and IL-17R showed good accuracy in identifying severe disease (AUC = 0.808 and 0.777, respectively) and were positively correlated with PCT and hs-CRP (all P < 0.05). Multivariate analysis identified IL-17, IL-17R, PCT, and hs-CRP as independent risk factors for severe bacterial pneumonia.</p><p><strong>Conclusions: </strong>IL-17 and IL-17R are elevated in bacterial pneumonia, demonstrating close association with disease severity and conventional markers. Their decline after treatment indicates therapeutic effectiveness. These cytokines show diagnostic potential and could help monitor disease progression and treatment response. Future research should confirm these findings in larger cohorts and investigate their interactions with other inflammatory pathways.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9715-9726"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Diabetic foot complications are among the most severe and costly complications of diabetes. This study aims to explore the effectiveness of a nurse-led multidisciplinary collaborative nursing model under the "Six-Profession Co-Management Model" in the nursing intervention for community-based patients with high-risk diabetic feet.
Methods: A prospective analysis was conducted from July to December 2023, involving 148 community-based DHRF patients. Participants were randomly allocated (1:1) to a control group receiving conventional nursing care, or an experimental group receiving nurse-led multidisciplinary interventions within the Six-Profession Co-management Model, alongside conventional care. Outcomes including laboratory measures (fasting and postprandial blood glucose, glycated hemoglobin, lipids), high-risk foot examination results, and scores from the Diabetic Foot Care Knowledge and Daily Care Behavior questionnaires were compared between groups before and after the 6-month intervention.
Results: No statistically significant differences were observed in baseline data between the two groups (P > 0.05). Before the intervention, there were no significant differences in laboratory indicators, high-risk foot examination results, or questionnaire scores between the two groups (P > 0.05). After the intervention, significant differences were observed in all these measures, with the experimental group demonstrating markedly better outcomes than the control group (P < 0.05).
Conclusion: The nurse-led multidisciplinary collaborative nursing model under the "Six-Profession Co-Management" framework is effective in managing community-based DHRF patients. It supports risk factor screening and assessment of foot care knowledge and behaviors, offering valuable guidance for early intervention.
{"title":"Promising community nursing effect on diabetic foot patients under the \"six-in-one\" collaborative management model.","authors":"Xiu-Jun He, Ya-Chun Zhou, Ya-Jun Ding, Yan-Zhen Lu, Ying Hu, Wei Chen, Jing-Jing Zhang","doi":"10.62347/JCYQ7972","DOIUrl":"10.62347/JCYQ7972","url":null,"abstract":"<p><strong>Background: </strong>Diabetic foot complications are among the most severe and costly complications of diabetes. This study aims to explore the effectiveness of a nurse-led multidisciplinary collaborative nursing model under the \"Six-Profession Co-Management Model\" in the nursing intervention for community-based patients with high-risk diabetic feet.</p><p><strong>Methods: </strong>A prospective analysis was conducted from July to December 2023, involving 148 community-based DHRF patients. Participants were randomly allocated (1:1) to a control group receiving conventional nursing care, or an experimental group receiving nurse-led multidisciplinary interventions within the Six-Profession Co-management Model, alongside conventional care. Outcomes including laboratory measures (fasting and postprandial blood glucose, glycated hemoglobin, lipids), high-risk foot examination results, and scores from the Diabetic Foot Care Knowledge and Daily Care Behavior questionnaires were compared between groups before and after the 6-month intervention.</p><p><strong>Results: </strong>No statistically significant differences were observed in baseline data between the two groups (P > 0.05). Before the intervention, there were no significant differences in laboratory indicators, high-risk foot examination results, or questionnaire scores between the two groups (P > 0.05). After the intervention, significant differences were observed in all these measures, with the experimental group demonstrating markedly better outcomes than the control group (P < 0.05).</p><p><strong>Conclusion: </strong>The nurse-led multidisciplinary collaborative nursing model under the \"Six-Profession Co-Management\" framework is effective in managing community-based DHRF patients. It supports risk factor screening and assessment of foot care knowledge and behaviors, offering valuable guidance for early intervention.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9759-9770"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808075/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To investigate the expression of the TLR2/NF-κB signaling pathway and the Aggregate Index of Systemic Inflammation (AISI) in patients with papillary thyroid carcinoma (PTC) and to evaluate their clinical relevance to prognosis.
Methods: In this retrospective study, we analyzed surgically resected tumor tissue samples from 273 patients with PTC (PTC group) and paired adjacent non-tumorous tissues (PT group), as well as 104 nodular goiter tissues (NG group). The AISI values, along with the positive rates and mRNA expression levels of TLR2, MyD88, and NF-κB, were compared among the three groups. Differences in these indicators were compared across PTC patients with different clinicopathologic features. All PTC patients were followed up for three years and categorized into a survival group (n = 70) and a death group (n = 203) based on prognosis, and between-group comparisons were performed. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the prognostic performance of each indicator. Kaplan-Meier survival curves were generated to compare overall survival between high- and low-expression subgroups stratified by TLR2, MyD88, NF-κB mRNA and AISI levels. Cox regression analysis was conducted to identify independent prognostic factors in PTC.
Results: Compared to the NG and PT groups, the PTC group showed higher AISI values, and protein positivity and mRNA expression of TLR2, MyD88, and NF-κB (all P<0.05). In the PTC group, the expression levels of these biomarkers and AISI values differed significantly according to tumor stage, lymph node metastasis, degree of differentiation, and extraglandular extension (P<0.05). Significant differences in differentiation grade, lymph node metastasis, extrathyroidal extension, TLR2, MyD88, NF-κB mRNA, and AISI levels were observed between the survival and death groups (P<0.05). The AUC values for predicting patient prognosis based on TLR2, MyD88, NF-κB mRNA, and AISI individually or in combination were 0.802, 0.795, 0.799, 0.815, and 0.818, respectively. Patients with low expression levels of TLR2, MyD88, NF-κB mRNA, and AISI had significantly longer overall survival compared to those with high expression levels (P<0.05).
Conclusion: Poor differentiation, extrathyroidal extension, and high AISI expression are independent factors for poor PTC prognosis. The TLR2/NF-κB signaling pathway and AISI are closely associated with tumor progression and have prognostic value.
目的:探讨TLR2/NF-κB信号通路与全身性炎症综合指数(AISI)在甲状腺乳头状癌(PTC)患者中的表达及其与预后的临床相关性。方法:回顾性分析273例PTC患者(PTC组)和配对的邻近非肿瘤组织(PT组),以及104例结节性甲状腺肿(NG组)手术切除的肿瘤组织样本。比较三组患者AISI值、TLR2、MyD88、NF-κB mRNA表达水平及阳性率。比较具有不同临床病理特征的PTC患者在这些指标上的差异。所有PTC患者随访3年,根据预后分为生存组(n = 70)和死亡组(n = 203),并进行组间比较。采用受试者工作特征(ROC)曲线分析评价各指标的预后表现。生成Kaplan-Meier生存曲线,比较TLR2、MyD88、NF-κ b mRNA和AISI水平分层的高表达亚组和低表达亚组的总生存率。采用Cox回归分析确定PTC的独立预后因素。结果:与NG组和PT组比较,PTC组AISI值较高,TLR2、MyD88、NF-κB蛋白阳性及mRNA表达均为PTC。结论:分化差、甲状腺外展、AISI高表达是PTC预后差的独立因素。TLR2/NF-κB信号通路和AISI与肿瘤进展密切相关,具有预后价值。
{"title":"Role of the TLR2/NF-κB signaling pathway and the aggregate index of systemic inflammation as prognostic indicators in papillary thyroid carcinoma.","authors":"Yanhong Ren, Guohua Sun, Xiang Huo, Jianlin He, Duting Wang, Kai Zhao","doi":"10.62347/RUQS5111","DOIUrl":"10.62347/RUQS5111","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the expression of the TLR2/NF-κB signaling pathway and the Aggregate Index of Systemic Inflammation (AISI) in patients with papillary thyroid carcinoma (PTC) and to evaluate their clinical relevance to prognosis.</p><p><strong>Methods: </strong>In this retrospective study, we analyzed surgically resected tumor tissue samples from 273 patients with PTC (PTC group) and paired adjacent non-tumorous tissues (PT group), as well as 104 nodular goiter tissues (NG group). The AISI values, along with the positive rates and mRNA expression levels of TLR2, MyD88, and NF-κB, were compared among the three groups. Differences in these indicators were compared across PTC patients with different clinicopathologic features. All PTC patients were followed up for three years and categorized into a survival group (n = 70) and a death group (n = 203) based on prognosis, and between-group comparisons were performed. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the prognostic performance of each indicator. Kaplan-Meier survival curves were generated to compare overall survival between high- and low-expression subgroups stratified by TLR2, MyD88, NF-κB mRNA and AISI levels. Cox regression analysis was conducted to identify independent prognostic factors in PTC.</p><p><strong>Results: </strong>Compared to the NG and PT groups, the PTC group showed higher AISI values, and protein positivity and mRNA expression of TLR2, MyD88, and NF-κB (all P<0.05). In the PTC group, the expression levels of these biomarkers and AISI values differed significantly according to tumor stage, lymph node metastasis, degree of differentiation, and extraglandular extension (P<0.05). Significant differences in differentiation grade, lymph node metastasis, extrathyroidal extension, TLR2, MyD88, NF-κB mRNA, and AISI levels were observed between the survival and death groups (P<0.05). The AUC values for predicting patient prognosis based on TLR2, MyD88, NF-κB mRNA, and AISI individually or in combination were 0.802, 0.795, 0.799, 0.815, and 0.818, respectively. Patients with low expression levels of TLR2, MyD88, NF-κB mRNA, and AISI had significantly longer overall survival compared to those with high expression levels (P<0.05).</p><p><strong>Conclusion: </strong>Poor differentiation, extrathyroidal extension, and high AISI expression are independent factors for poor PTC prognosis. The TLR2/NF-κB signaling pathway and AISI are closely associated with tumor progression and have prognostic value.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9695-9704"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.62347/FYWL8005
Yuwei Liu, Lin Xu, Yufei Chang, Xiaoyou Chen
Objective: To evaluate the clinical value of nanopore sequencing technology (NST) for the early diagnosis and resistance guidance of Mycoplasma pneumoniae (MP) infection in children.
Methods: We analyzed four pediatric patients with MP pneumonia. Sputum specimens were subjected to NST, and results were compared with serological MP-IgM testing, nucleic acid detection, and chest CT.
Results: In all four cases, MP-IgM yielded false-negative or weakly positive results within the first 5 days. In contrast, NST provided a definitive diagnosis within 24 hours of admission, detecting MP with sequence reads ranging from 14 to 3024 and simultaneously identifying the macrolide-resistant A2063G mutation in the 23S rRNA gene. This led to a confirmed diagnosis 3-7 days earlier than serological methods. Blood cultures were negative in all cases.
Conclusion: NST overcomes the limitations and delay of traditional methods, enabling rapid and accurate diagnosis of MP infection and concurrent detection of resistance mutations. Its integration into clinical practice may significantly improve the management of pediatric MP pneumonia.
{"title":"Nanopore sequencing enables rapid diagnosis and drug resistance profiling in refractory <i>Mycoplasma pneumoniae</i> pneumonia: a case report.","authors":"Yuwei Liu, Lin Xu, Yufei Chang, Xiaoyou Chen","doi":"10.62347/FYWL8005","DOIUrl":"10.62347/FYWL8005","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical value of nanopore sequencing technology (NST) for the early diagnosis and resistance guidance of <i>Mycoplasma pneumoniae</i> (MP) infection in children.</p><p><strong>Methods: </strong>We analyzed four pediatric patients with MP pneumonia. Sputum specimens were subjected to NST, and results were compared with serological MP-IgM testing, nucleic acid detection, and chest CT.</p><p><strong>Results: </strong>In all four cases, MP-IgM yielded false-negative or weakly positive results within the first 5 days. In contrast, NST provided a definitive diagnosis within 24 hours of admission, detecting MP with sequence reads ranging from 14 to 3024 and simultaneously identifying the macrolide-resistant A2063G mutation in the 23S rRNA gene. This led to a confirmed diagnosis 3-7 days earlier than serological methods. Blood cultures were negative in all cases.</p><p><strong>Conclusion: </strong>NST overcomes the limitations and delay of traditional methods, enabling rapid and accurate diagnosis of MP infection and concurrent detection of resistance mutations. Its integration into clinical practice may significantly improve the management of pediatric MP pneumonia.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9460-9465"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808016/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145996985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.62347/XUCP4161
Fabin Huang, Yu Liu, Shaoling Qiu
Objective: To retrospectively explore how sevoflurane + sufentanil/remifentanil versus propofol + sufentanil/remifentanil impacts clinical outcomes in laparoscopic herniorrhaphy-treated adults.
Methods: We enrolled 102 adult patients grouped into propofol (n=50) and sevoflurane (n=52) groups. Inter-group comparisons were made regarding operative duration, time to induction, extubation, emergence, and consciousness recovery, agitation incidence, first ambulation time, length of stay, and gastrointestinal recovery. Adverse events, hemodynamic parameters, as well as preoperative and postoperative stress markers, inflammatory cytokines, and pain mediators, were also discussed.
Results: The sevoflurane group had statistically shorter times to extubation, consciousness recovery, first ambulation, and gastrointestinal restoration, along with lower agitation and overall adverse event rates. Shorter anesthesia emergence time and more stable hemodynamic parameters were also found in patients receiving sevoflurane compared to the propofol cohort. Better performance in postoperative stress response, inflammatory markers, and pain mediators (except for a milder decrease in β-endorphin [β-EP]) was also determined in sevoflurane-treated patients. No notable intergroup differences were identified in the durations of surgery, induction, and hospitalization.
Conclusion: Compared to the propofol combination, the sevoflurane-sufentanil/remifentanil regimen applied to adult laparoscopic hernia repair patients contributed to superior clinical outcomes.
{"title":"Impacts of sufentanil/remifentanil plus sevoflurane versus propofol in adults undergoing laparoscopic herniorrhaphy.","authors":"Fabin Huang, Yu Liu, Shaoling Qiu","doi":"10.62347/XUCP4161","DOIUrl":"10.62347/XUCP4161","url":null,"abstract":"<p><strong>Objective: </strong>To retrospectively explore how sevoflurane + sufentanil/remifentanil versus propofol + sufentanil/remifentanil impacts clinical outcomes in laparoscopic herniorrhaphy-treated adults.</p><p><strong>Methods: </strong>We enrolled 102 adult patients grouped into propofol (n=50) and sevoflurane (n=52) groups. Inter-group comparisons were made regarding operative duration, time to induction, extubation, emergence, and consciousness recovery, agitation incidence, first ambulation time, length of stay, and gastrointestinal recovery. Adverse events, hemodynamic parameters, as well as preoperative and postoperative stress markers, inflammatory cytokines, and pain mediators, were also discussed.</p><p><strong>Results: </strong>The sevoflurane group had statistically shorter times to extubation, consciousness recovery, first ambulation, and gastrointestinal restoration, along with lower agitation and overall adverse event rates. Shorter anesthesia emergence time and more stable hemodynamic parameters were also found in patients receiving sevoflurane compared to the propofol cohort. Better performance in postoperative stress response, inflammatory markers, and pain mediators (except for a milder decrease in β-endorphin [β-EP]) was also determined in sevoflurane-treated patients. No notable intergroup differences were identified in the durations of surgery, induction, and hospitalization.</p><p><strong>Conclusion: </strong>Compared to the propofol combination, the sevoflurane-sufentanil/remifentanil regimen applied to adult laparoscopic hernia repair patients contributed to superior clinical outcomes.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"10008-10016"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.62347/MVTV2288
Qianli Ma, Weina Li, Lin Chen, Xunhui Zhuang
Objectives: To establish a clinical and CT-based diagnostic model to predict high-grade lung adenocarcinoma (LAC) in patients with idiopathic pulmonary fibrosis (IPF).
Methods: A total of 289 LAC-IPF patients were enrolled retrospectively and were divided into training (n=171) and test sets (n=118). In each set, the patients were divided into a low-grade LAC group and high-grade LAC group according to pathologic findings. Clinical and high-resolution CT (HRCT) features were analyzed by binary logistic regression analysis to select independent predictors for high-grade LAC by building three models: the clinical model, the radiologic model, and the combined model integrating the independent clinical and radiologic factors. The discriminative performance of the three models was assessed using the receiver operating characteristic (ROC). The model with the best diagnostic performance was verified in the test set.
Results: There was no significant difference between the training and test sets regarding clinical and radiologic factors (P>0.05). The usual interstitial pneumonia (UIP) pattern of IPF, solid morphology of the tumor, cytokeratin 19 fragments (CYFRA21-1, the cutoff value: 2.85 ng/mL) and smoking history were identified as independent predictors for high-grade LAC. The combined model showed the best discriminative performance (AUC: 0.955 in the training set and 0.853 in the test set), with sensitivity, specificity, and accuracy of 94.0%, 87.1%, and 91.2%, respectively.
Conclusions: A clinical and CT-based model can be used as an effective tool to predict high-grade LAC in IPF patients.
{"title":"A clinical and CT-based model for differentiating high-grade from low-grade lung adenocarcinoma in patients with idiopathic pulmonary fibrosis.","authors":"Qianli Ma, Weina Li, Lin Chen, Xunhui Zhuang","doi":"10.62347/MVTV2288","DOIUrl":"10.62347/MVTV2288","url":null,"abstract":"<p><strong>Objectives: </strong>To establish a clinical and CT-based diagnostic model to predict high-grade lung adenocarcinoma (LAC) in patients with idiopathic pulmonary fibrosis (IPF).</p><p><strong>Methods: </strong>A total of 289 LAC-IPF patients were enrolled retrospectively and were divided into training (n=171) and test sets (n=118). In each set, the patients were divided into a low-grade LAC group and high-grade LAC group according to pathologic findings. Clinical and high-resolution CT (HRCT) features were analyzed by binary logistic regression analysis to select independent predictors for high-grade LAC by building three models: the clinical model, the radiologic model, and the combined model integrating the independent clinical and radiologic factors. The discriminative performance of the three models was assessed using the receiver operating characteristic (ROC). The model with the best diagnostic performance was verified in the test set.</p><p><strong>Results: </strong>There was no significant difference between the training and test sets regarding clinical and radiologic factors (<i>P</i>>0.05). The usual interstitial pneumonia (UIP) pattern of IPF, solid morphology of the tumor, cytokeratin 19 fragments (CYFRA21-1, the cutoff value: 2.85 ng/mL) and smoking history were identified as independent predictors for high-grade LAC. The combined model showed the best discriminative performance (AUC: 0.955 in the training set and 0.853 in the test set), with sensitivity, specificity, and accuracy of 94.0%, 87.1%, and 91.2%, respectively.</p><p><strong>Conclusions: </strong>A clinical and CT-based model can be used as an effective tool to predict high-grade LAC in IPF patients.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9412-9421"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: This study aimed to identify the risk factors associated with delayed drug metabolism during high-dose methotrexate (HD-MTX) therapy and to analyze the relationship between delayed metabolism and post-treatment toxic adverse effects.
Methods: A retrospective analysis was performed on 189 patients with acute lymphoblastic leukemia who received HD-MTX therapy at Xi'an Gaoxin Hospital between February 2018 and May 2023. Serum MTX concentrations were measured at 24, 48, and 72 hours after each HD-MTX administration (cycle), with a 48-hour concentration ≥ 1 μmol/L defining delayed metabolism on a per-cycle basis. Clinical characteristics and laboratory parameters were collected, and univariate and multivariate logistic regression analyses were conducted using SPSS version 27.00 and R version 4.3.3 to determine the risk factors for delayed metabolism. Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive performance of each significant factor.
Results: Significant differences were observed between the delayed cycles (n = 105) and the non-delayed cycles (n = 450) across several clinical and laboratory variables, including age, body mass index (BMI), MTX dosage, activated partial thromboplastin time (APTT), and D-dimer (DD). Logistic regression analysis identified age, BMI, body surface area, MTX dosage, APTT, fibrinogen, DD, albumin, creatinine clearance rate, and phosphorus levels as independent risk factors for delayed metabolism. ROC curve analysis demonstrated that DD exhibited high predictive accuracy for delayed metabolism (area under the curve = 0.833). Moreover, delayed metabolism was significantly associated with a higher incidence of treatment-related toxicities, including mucosal injury, myelosuppression, renal impairment, and gastrointestinal reactions.
Conclusion: Delayed MTX metabolism is influenced by multiple clinical and biochemical factors, with DD emerging as a key predictor. Patients experiencing delayed metabolism are at greater risk for severe treatment-related toxicities. Clinicians should closely monitor these high-risk patients and consider timely preventive or corrective interventions to mitigate adverse outcomes.
{"title":"Association between delayed methotrexate metabolism, coagulation function, and adverse reactions in patients with acute lymphoblastic leukemia receiving high-dose methotrexate treatment.","authors":"Jing Xu, Guoqiang Huang, Xiaopeng Liu, Xiaoying Zhao, Xin Chen","doi":"10.62347/GDXH3501","DOIUrl":"10.62347/GDXH3501","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to identify the risk factors associated with delayed drug metabolism during high-dose methotrexate (HD-MTX) therapy and to analyze the relationship between delayed metabolism and post-treatment toxic adverse effects.</p><p><strong>Methods: </strong>A retrospective analysis was performed on 189 patients with acute lymphoblastic leukemia who received HD-MTX therapy at Xi'an Gaoxin Hospital between February 2018 and May 2023. Serum MTX concentrations were measured at 24, 48, and 72 hours after each HD-MTX administration (cycle), with a 48-hour concentration ≥ 1 μmol/L defining delayed metabolism on a per-cycle basis. Clinical characteristics and laboratory parameters were collected, and univariate and multivariate logistic regression analyses were conducted using SPSS version 27.00 and R version 4.3.3 to determine the risk factors for delayed metabolism. Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive performance of each significant factor.</p><p><strong>Results: </strong>Significant differences were observed between the delayed cycles (n = 105) and the non-delayed cycles (n = 450) across several clinical and laboratory variables, including age, body mass index (BMI), MTX dosage, activated partial thromboplastin time (APTT), and D-dimer (DD). Logistic regression analysis identified age, BMI, body surface area, MTX dosage, APTT, fibrinogen, DD, albumin, creatinine clearance rate, and phosphorus levels as independent risk factors for delayed metabolism. ROC curve analysis demonstrated that DD exhibited high predictive accuracy for delayed metabolism (area under the curve = 0.833). Moreover, delayed metabolism was significantly associated with a higher incidence of treatment-related toxicities, including mucosal injury, myelosuppression, renal impairment, and gastrointestinal reactions.</p><p><strong>Conclusion: </strong>Delayed MTX metabolism is influenced by multiple clinical and biochemical factors, with DD emerging as a key predictor. Patients experiencing delayed metabolism are at greater risk for severe treatment-related toxicities. Clinicians should closely monitor these high-risk patients and consider timely preventive or corrective interventions to mitigate adverse outcomes.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9566-9579"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.62347/MVCU9398
Yi Zhu, Ping Hu, Youhua Xu, Niansong Wang
Objective: This study aimed to investigate the principles of acupoint selection and the prescription characteristics of acupuncture therapy for renal edema.
Methods: Data mining technology was adopted to identify high-frequency acupoints and commonly used prescription combinations. Eight rats were selected as the control group without drug intervention, while the remaining rats were divided into the control group, model group, sham acupuncture group, and acupuncture group. Serum Ig-M and Ig-G expression levels were assessed by western blotting, and renal expression of AQP2 and AQP3 was examined using immunofluorescence.
Results: In prescriptions for renal edema, the five most frequently selected acupoints were Shenshu (BL23), Shuishui (ST28), Guanyuan (CV4), Pishu (BL20), and Zusanli (ST36). The four most frequently involved meridians were the Bladder Meridian of Foot-Taiyang, the Conception Vessel, the Kidney Meridian of Foot-Shaoyin, and the Governor Vessel. Commonly used acupoints included Yinlingquan (SP9), Yongquan (KI1), Guanyuan (CV4), Pishu (BL20), Zusanli (ST36), Shenque (CV8), and Shuifen (CV9). Compared to the blank group, the model group exhibited significantly increased serum IgM and IgG expression, while these levels were reduced in the acupuncture group. In contrast, renal AQP2 and AQP3 expression was significantly decreased in the model group relative to the blank group (P<0.05).
Conclusion: Acupuncture targeting the Bladder Meridian of Foot-Taiyang, the Conception Vessel, the Kidney Meridian of Foot-Shaoyin, and the Governor Vessel can alleviate renal edema by enhancing renal aquaporin expression and attenuating inflammatory response.
{"title":"Acupuncture alleviates renal edema through upregulation of renal aquaporin expression.","authors":"Yi Zhu, Ping Hu, Youhua Xu, Niansong Wang","doi":"10.62347/MVCU9398","DOIUrl":"10.62347/MVCU9398","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the principles of acupoint selection and the prescription characteristics of acupuncture therapy for renal edema.</p><p><strong>Methods: </strong>Data mining technology was adopted to identify high-frequency acupoints and commonly used prescription combinations. Eight rats were selected as the control group without drug intervention, while the remaining rats were divided into the control group, model group, sham acupuncture group, and acupuncture group. Serum Ig-M and Ig-G expression levels were assessed by western blotting, and renal expression of AQP2 and AQP3 was examined using immunofluorescence.</p><p><strong>Results: </strong>In prescriptions for renal edema, the five most frequently selected acupoints were Shenshu (BL23), Shuishui (ST28), Guanyuan (CV4), Pishu (BL20), and Zusanli (ST36). The four most frequently involved meridians were the Bladder Meridian of Foot-Taiyang, the Conception Vessel, the Kidney Meridian of Foot-Shaoyin, and the Governor Vessel. Commonly used acupoints included Yinlingquan (SP9), Yongquan (KI1), Guanyuan (CV4), Pishu (BL20), Zusanli (ST36), Shenque (CV8), and Shuifen (CV9). Compared to the blank group, the model group exhibited significantly increased serum IgM and IgG expression, while these levels were reduced in the acupuncture group. In contrast, renal AQP2 and AQP3 expression was significantly decreased in the model group relative to the blank group (<i>P</i><0.05).</p><p><strong>Conclusion: </strong>Acupuncture targeting the Bladder Meridian of Foot-Taiyang, the Conception Vessel, the Kidney Meridian of Foot-Shaoyin, and the Governor Vessel can alleviate renal edema by enhancing renal aquaporin expression and attenuating inflammatory response.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9786-9799"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.62347/ZYBK5288
Jun Dong, Hui Su, Tingting Zhou, Xiaoming Li, Hui Li
Objective: This study aimed to investigate the role of ferroptosis-related genes and pathways in cartilage degeneration in knee osteoarthritis (KOA) and to identify potential therapeutic targets.
Methods: Integrated bioinformatics analysis of public KOA transcriptomic datasets was performed to identify differentially expressed ferroptosis-related genes. Key pathways and hub genes were further validated using a surgically-induced KOA mouse model and clinical cartilage samples through histology, immunohistochemistry, micro-CT, ELISA, western blot, and qPCR.
Results: Significant iron deposition, mitochondrial damage, and dysregulation of ferroptosis markers (e.g., decreased GPX4 and increased p53) were observed in KOA cartilage. Key genes such as MMP2, SPP1, MYC, and BNIP3 were identified, and pathways including mTOR and HIF-1 signaling were enriched. Experimental results consistently indicated enhanced ferroptosis and matrix degradation in both mouse and human OA samples.
Conclusion: Ferroptosis contributes significantly to KOA progression through iron overload, lipid peroxidation, and dysregulated metabolic pathways, providing new insight for targeted therapeutic strategies.
{"title":"Ferroptosis-related genes and pathways in knee osteoarthritis cartilage degeneration: discovered by bioinformatics technology and in vivo experimental verification.","authors":"Jun Dong, Hui Su, Tingting Zhou, Xiaoming Li, Hui Li","doi":"10.62347/ZYBK5288","DOIUrl":"10.62347/ZYBK5288","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the role of ferroptosis-related genes and pathways in cartilage degeneration in knee osteoarthritis (KOA) and to identify potential therapeutic targets.</p><p><strong>Methods: </strong>Integrated bioinformatics analysis of public KOA transcriptomic datasets was performed to identify differentially expressed ferroptosis-related genes. Key pathways and hub genes were further validated using a surgically-induced KOA mouse model and clinical cartilage samples through histology, immunohistochemistry, micro-CT, ELISA, western blot, and qPCR.</p><p><strong>Results: </strong>Significant iron deposition, mitochondrial damage, and dysregulation of ferroptosis markers (e.g., decreased GPX4 and increased p53) were observed in KOA cartilage. Key genes such as MMP2, SPP1, MYC, and BNIP3 were identified, and pathways including mTOR and HIF-1 signaling were enriched. Experimental results consistently indicated enhanced ferroptosis and matrix degradation in both mouse and human OA samples.</p><p><strong>Conclusion: </strong>Ferroptosis contributes significantly to KOA progression through iron overload, lipid peroxidation, and dysregulated metabolic pathways, providing new insight for targeted therapeutic strategies.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9516-9530"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}